Teishima, J., Inoue, S., Hayashi, T., Mita, K., Hasegawa, Y., Kato, M., Kajiwara, M., Shigeta, M., Maruyama, S., Moriyama, H., & Fujiwara, S. (2020). Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. Canadian Urological Association Journal, 14(11), E582–7. https://doi.org/10.5489/cuaj.6413